CHARLOTTE, N.C., Oct. 24, 2025 – Prenetics Global Limited, also referred to as “Prenetics” or “the Company,” a prominent health sciences firm, announced today the initiation of a public offering. This offering includes shares of its Class A Ordinary Shares (or prefunded warrants instead) and common warrants, collectively termed “the Offering.” The Company plans to utilize the funds generated from this offering to support the worldwide growth of IM8, spurred by its rapid expansion, and for the deliberate acquisition of Bitcoin (BTC) as part of its innovative strategy focusing on both health and financial assets.
Completion of the Offering is contingent on market conditions, and there is no guarantee regarding if or when it will conclude, nor its final scope or specifics.
Dominari Securities LLC has been appointed as the exclusive placement agent for this Offering.
This Offering is being conducted under an existing shelf registration statement on Form F-3, as modified (No. 333-288824), which the U.S. Securities and Exchange Commission (“SEC”) declared effective on September 11, 2025. A preliminary prospectus supplement, along with a related shelf prospectus (referred to as “Shelf Prospectus”) detailing the Offering’s terms, will be submitted to the SEC and can be accessed via the SEC’s official website at https://www.sec.gov. Once available, digital copies of the preliminary prospectus supplement (which, with the final prospectus supplement for this Offering, forms the “Prospectus Supplement”) and the corresponding shelf prospectus can be requested from Dominari Securities LLC, specifically the Syndicate Department, at 725 5th Ave 23 Floor, New York, NY 10022, via email at info@dominarisecurities.com, or by calling (212) 393-4500.
Prospective investors are advised to thoroughly review the prospectus supplement, the Shelf Prospectus, and all other Company filings with the SEC related to this Offering. These documents, incorporated by reference into the Prospectus Supplement and Shelf Prospectus, offer comprehensive details about the Company and the Offering.
This announcement does not represent an offer to sell or a solicitation to purchase, nor will any securities be sold in any state or jurisdiction where such actions would be illegal without prior registration or qualification under local securities regulations.
Concerning Prenetics
Prenetics (NASDAQ: PRE) stands as a prominent health sciences enterprise, actively reshaping the landscape of health and extended life through IM8. This brand, a key consumer offering co-established with David Beckham, has emerged as one of the globe’s most rapidly expanding supplement brands.
Prenetics, recognized as the inaugural consumer health company to institute a Bitcoin Treasury, maintains its pioneering role where health advancements converge with digital assets. The Company acquires 1 Bitcoin daily, accumulating a total of 272 BTC as of October 24, 2025.
Statements Regarding Future Expectations
This press release includes statements that look to the future. Such statements are issued under the “safe harbor” stipulations of the U.S. Private Securities Litigation Reform Act of 1995. Indicators of these forward-looking statements include terms like “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and comparable expressions. Prenetics might also issue written or verbal forward-looking statements in its regular reports to the U.S. Securities and Exchange Commission, in its yearly shareholder report, in press releases and other written documents, and orally through its officers, directors, or staff to external parties. Statements not based on historical facts, including those concerning Prenetics’ beliefs and future outlook, qualify as forward-looking. Such statements inherently carry risks and uncertainties. Various elements could lead actual outcomes to diverge significantly from those expressed in any forward-looking statement. These factors include, but are not limited to: the Company’s capacity to finalize the offering; its ability to implement its updated Bitcoin treasury strategy; Bitcoin’s market volatility; the Company’s aptitude for managing its expansion and growth; its capability to contend within the intensely competitive consumer health sector; and other inherent risks and uncertainties. Additional details concerning these and other risks can be found in Prenetics’ submissions to the U.S. Securities and Exchange Commission. All data presented in this press release is current as of its publication date, and Prenetics disclaims any duty to revise any forward-looking statement, unless mandated by relevant law.
For Investor Relations Inquiries:
Angela Cheung
Investor Relations / Corporate Finance
